We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+4.93%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$22.8B
AUM Growth
+$1.89B
(+9%)
Cap. Flow
+$423M
Cap. Flow
% of AUM
1.85%
Top 10 Holdings %
Top 10 Hldgs %
15.02%
Holding
3,143
New
326
Increased
869
Reduced
968
Closed
274
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Constellation Brands
STZ
|
+$125M |
| 2 |
Southwest Airlines
LUV
|
+$121M |
| 3 |
Lam Research
LRCX
|
+$101M |
| 4 |
DuPont de Nemours
DD
|
+$92.3M |
| 5 |
NetApp
NTAP
|
+$74.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DD
Du Pont De Nemours E I
DD
|
+$91.2M |
| 2 |
Tyson Foods
TSN
|
+$72.4M |
| 3 |
Merck
MRK
|
+$67.7M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
+$67.1M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$65.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.59% |
| 2 | Technology | 15.59% |
| 3 | Financials | 13.54% |
| 4 | Industrials | 10.36% |
| 5 | Consumer Discretionary | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Neogen
NEOG
$2.05B
| $283K | ﹤0.01% |
9,765
-286
| -3% | -$7.35K |
|
977
PVH
PVH
$3.71B
| $283K | ﹤0.01% |
2,260
-127
| -5% | -$15.5K |
|
978
BlackRock TCP Capital
TCPC
$265M
| $283K | ﹤0.01% |
17,189
-7,971
| -32% | -$132K |
|
979
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$50.7B
| $282K | ﹤0.01% |
9,120
| – | – |
|
980
Vanguard Energy ETF
VDE
$10.1B
| $280K | ﹤0.01% |
3,000
-1,115
| -27% | -$98.9K |
|
981
Columbia Sportswear
COLM
$3.19B
| $278K | ﹤0.01% |
4,523
| – | – |
|
982
Liberty Global Class C
LBTYK
$3.27B
| $278K | ﹤0.01% |
8,524
+4,648
| +120% | +$150K |
|
983
Petrobras
PBR
$121B
| $277K | ﹤0.01% |
27,638
+26,223
| +1,853% | +$238K |
|
984
Interface
TILE
$1.91B
| $276K | ﹤0.01% |
12,624
+12,390
| +5,295% | +$241K |
|
|
MNTA
985
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $276K | ﹤0.01% |
14,958
-26,921
| -64% | -$450K |
|
986
NBT Bancorp
NBTB
$2.72B
| $275K | ﹤0.01% |
7,532
| – | – |
|
987
Descartes Systems
DSGX
$5.84B
| $274K | ﹤0.01% |
10,025
+300
| +3% | +$7.93K |
|
988
Vanguard Total International Stock ETF
VXUS
$153B
| $268K | ﹤0.01% |
4,900
+4,000
| +444% | +$215K |
|
989
Avient
AVNT
$3.45B
| $267K | ﹤0.01% |
6,684
-10,268
| -61% | -$383K |
|
990
Baidu
BIDU
$35.8B
| $267K | ﹤0.01% |
1,081
+187
| +21% | +$40.8K |
|
991
Baker Hughes
BKR
$56.8B
| $267K | ﹤0.01% |
+7,309
| New | +$259K |
|
992
Goldman Sachs ActiveBeta Emerging Markets Equity ETF
GEM
$1.63B
| $267K | ﹤0.01% |
+8,000
| New | +$266K |
|
993
Glaukos
GKOS
$9.02B
| $266K | ﹤0.01% |
8,099
-7,581
| -48% | -$288K |
|
994
Bread Financial
BFH
$4.21B
| $265K | ﹤0.01% |
1,505
+177
| +13% | +$32.8K |
|
995
Freeport-McMoran
FCX
$90B
| $265K | ﹤0.01% |
18,930
-113,313
| -86% | -$1.59M |
|
996
Vertex Pharmaceuticals
VRTX
$121B
| $265K | ﹤0.01% |
1,754
+99
| +6% | +$14.9K |
|
997
Helmerich & Payne
HP
$3.53B
| $263K | ﹤0.01% |
5,085
-193,158
| -97% | -$9.56M |
|
|
GS.PRB.CL
998
DELISTED
Goldman Sachs Group Depositary Shares (1/1000 Interest of 6.2% Non-Cum. Prfrd. Stock, Series B) Call
GS.PRB.CL
| $262K | ﹤0.01% |
10,000
| – | – |
|
999
Hartford Financial Services
HIG
$38.5B
| $260K | ﹤0.01% |
4,710
-152
| -3% | -$8.27K |
|
|
MTOR
1000
DELISTED
MERITOR, Inc.
MTOR
| $260K | ﹤0.01% |
10,000
-185
| -2% | -$3.67K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q3 2017 Portfolio in Review
As of Q3 2017, Glenmede Trust held 3,143 positions worth $22.8B, up 9% from $20.9B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Glenmede Trust's Q3 2017 filing shows 326 new, 869 increased, 968 reduced and 274 closed positions. Its largest new stake was Five Below: 1,137,870 shares worth $62.4M. The largest sale was Du Pont De Nemours E I, an estimated $91.2M.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Technology and Financials.
- Glenmede Trust's largest Q3 2017 buy was Five Below: 1,137,870 shares worth $62.4M.
- Glenmede Trust added most to Constellation Brands in Q3 2017, an estimated $125M increase.
- Glenmede Trust's biggest Q3 2017 reduction was Tyson Foods, cutting an estimated $72.4M.
- Glenmede Trust fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $91.2M.
- Glenmede Trust's ten largest holdings make up 15% of its $22.8B portfolio in Q3 2017.
- Glenmede Trust opened 326 new positions and closed 274 in Q3 2017.
- Glenmede Trust's portfolio value rose 9% quarter-over-quarter to $22.8B.
Based on Glenmede Trust's 13F filing for Q3 2017, filed 14 Nov 2017.